- DocumentoA BRIEF INSIGHT ON DUCHENNE MUSCULAR DYSTROPHY (DMD)caricato daRAPPORTS DE PHARMACIE
- DocumentoEVALUATION OF CLINICAL OUTCOMES WITH METFORMIN THERAPY IN SOUTH INDIAN PCOS WOMENcaricato daRAPPORTS DE PHARMACIE
- DocumentoDEVELOPMENT AND EVALUATION OF POLOXAMER BASED NANOGEL OF RUTIN BY USING SIMPLEX-LATTICE MIXTURE DESIGNcaricato daRAPPORTS DE PHARMACIE
- DocumentoANTIOXIDANT, ANTIMICROBIAL AND SUN PROTECTION FACTOR DETERMINATION OF PHYLLANTHUS ACIDUScaricato daRAPPORTS DE PHARMACIE
- DocumentoANTIOXIDANT, ANTIMICROBIAL AND SPF PROTECTIVE ACTIVITY OF CUCURBITA MOSCHATA, CUCURBITA RETICULATA AND CLITORIA TERNATEAcaricato daRAPPORTS DE PHARMACIE
- DocumentoPREPARATION AND EVALUATION OF WOUND HEALING ACTIVITY OF URSOLIC ACID NANOEMULGEL FORMULATIONS IN RATScaricato daRAPPORTS DE PHARMACIE
- DocumentoEVALUATION OF IN-VITRO ANTIOXIDANT POTENTIAL ON ETHANOLIC EXTRACT OF ROOT OF SMILAX CHINAcaricato daRAPPORTS DE PHARMACIE
- DocumentoTHERAPEUTIC INVESTIGATION OF GALIC ACID ON PACLITAXEL-INDUCED MOTOR-INCOORDINATION IN MUS MUSCULUScaricato daRAPPORTS DE PHARMACIE
- DocumentoFORMULATION AND OPTIMIZATION OF LIPOSOMES INCORPORATING CYCLODEXTRIN– CLOPIDOGREL BASED GELcaricato daRAPPORTS DE PHARMACIE
- DocumentoPHYTOCHEMICAL ESSENCES OF FOUR HYBRID FLOWER PLUMERIA ACUMINATA IN POLAR AND NON-POLAR SOLVENTS EXTRACTcaricato daRAPPORTS DE PHARMACIE
- DocumentoANIMAL MODEL FOR CARPAL TUNNEL SYNDROME BY CHRONIC CONSTRICTION OF THE MEDIAN NERVE IN RATScaricato daRAPPORTS DE PHARMACIE
- DocumentoA MINI REVIEW OF NANOCRYSTALScaricato daRAPPORTS DE PHARMACIE
- DocumentoEFFECT OF EDARAVONE IN ISONIAZID-INDUCED HEPATOTOXICITY IN SPRAGUE DAWLEY RATScaricato daRAPPORTS DE PHARMACIE
- DocumentoPREPARATION, CHARACTERIZATION AND OPTIMIZATION OF CARVEDILOL- β CYCLODEXTRIN LIPOSOMAL BASED POLYMERIC GELcaricato daRAPPORTS DE PHARMACIE
- DocumentoDEVELOPMENT AND IN-VITRO EVALUATION OF CATECHIN LOADED ETHOSOMAL GEL FOR TOPICAL DELIVERYcaricato daRAPPORTS DE PHARMACIE
- DocumentoA MINI REVIEW ON NANOEMULSIONcaricato daRAPPORTS DE PHARMACIE
- DocumentoFORMULATION AND OPTIMIZATION OF LOVASTATIN-Β-CYCLODEXTRIN LOADED LIPOSOMAL GELS USING BOX-BEHNKEN DESIGNcaricato daRAPPORTS DE PHARMACIE
- DocumentoDEVELOPMENT AND OPTIMIZATION OF MONTELUKAST β-CYCLODEXTRIN LOADED LIPOSOMAL GELcaricato daRAPPORTS DE PHARMACIE
- DocumentoA MINI REVIEWcaricato daRAPPORTS DE PHARMACIE
- DocumentoNANOGELcaricato daRAPPORTS DE PHARMACIE
- DocumentoEVALUATION OF HORMONAL EFFICACY OF METFORMIN THERAPY IN POLYCYSTIC OVARY SYNDROMEcaricato daRAPPORTS DE PHARMACIE
- DocumentoEFFECT OF PEGYLATED POLYPROPYLENE IMINE DENDRIMERS LOADED IMATINIB FOR ANTI-TUMOR ACTIVITYcaricato daRAPPORTS DE PHARMACIE
- DocumentoSYNTHESIS AND CHARACTERIZATION OF PEGYLATED POLYPROPYLENEIMINE (PPI) DENDRIMER LOADED PREDNISOLONE FOR ANTILEUKEMIC ACTIVITYcaricato daRAPPORTS DE PHARMACIE
- DocumentoHERBAL REVIEW ON NYCTANTHES ARBORTRISTIS LINNcaricato daRAPPORTS DE PHARMACIE
- DocumentoDEVELOPMENT AND CHARACTERIZATION OF QUERCETIN NANOGELS BY USING SIMPLEX-LATTICE MIXTURE DESIGNcaricato daRAPPORTS DE PHARMACIE
- DocumentoOPTIMIZATION AND IN-VITRO CHARACTERIZATION OF ERYTHROMYCIN NANOGELS BY USING SIMPLEX-LATTICE MIXTURE DESIGNcaricato daRAPPORTS DE PHARMACIE
- DocumentoA SHORT COMMUNICATION ON THE MOLECULAR EXPRESSION ON TNBC TRIPLE NEGATIVE BREAST CANCERcaricato daRAPPORTS DE PHARMACIE
- DocumentoMOLECULAR ANALYSIS OF KEY PROTEIN PATTERN FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER (TNBC)caricato daRAPPORTS DE PHARMACIE
- DocumentoA SHORT COMMUNICATION ON PLGA AS A MAGIC POLYMER FOR THE TARGETTED DRUG DELIVERY SYSTEMcaricato daRAPPORTS DE PHARMACIE
- DocumentoIn this work, the purpose of the study was to formulate and optimize azilsartan nanoparticles by employing factorial design. The nanoparticles were prepared successfully with a modified emulsification method by using biodegradable and biocompatible polymer poly (L-lactide) (PLA). Various process parameters were manipulated to investigate their effects on particle size, polydispersity index, entrapment efficiency and percentage of cumulative drug release after 12 hours of formulated nanoparticles. In addition, morphology and compatibility between the drug and polymer of nanoparticles were studied with scanning electron microscope (SEM) and FTIR studies. The optimized formulation had a particle size range of 267.14 - 280.01 nm, PDI range of 0.101-0.361, entrapment efficiency range of 69.14 - 84.72% and % CDR after 12 hours 56.11 - 67.01%. The nanoparticles were confirmed to be spherical in shape by SEM results while FTIR results established the compatibility of components of the formulatcaricato daRAPPORTS DE PHARMACIE
- DocumentoDESIGN, OPTIMIZATION AND CHARACTERIZATION OF AZILSARTAN NANOPARTICLES USING DESIGN-EXPERT® SOFTWARE VERSION 11caricato daRAPPORTS DE PHARMACIE
- DocumentoBRINE SHRIMP CYTOTOXICITY ACTIVITY FOR DIFFERENT PARTS OF HYMENOCALLIS LITTORALIScaricato daRAPPORTS DE PHARMACIE
- DocumentoDEVELOPMENT AND CHARACTERIZATION OF PROMISING NANOPARTICULATE DRUG DELIVERY SYSTEMS CONTAINING QUERCETINcaricato daRAPPORTS DE PHARMACIE
- DocumentoPHYTOCHEMICAL EVALUATION OF MIMUSOPS ELENGI LINN BARKcaricato daRAPPORTS DE PHARMACIE
- DocumentoBOX-BEHNKEN DESIGN FORMULATION OPTIMIZATION AND IN VITRO CHARACTERIZATION OF RUTIN -LOADED PLA NANOPARTICLES USING DESIGN-EXPERT SOFTWAREcaricato daRAPPORTS DE PHARMACIE
- DocumentoDEVELOPMENT AND CHARACTERIZATION OF QUERCETIN NANOGELS BY USING SIMPLEX-LATTICE MIXTURE DESIGNcaricato daRAPPORTS DE PHARMACIE
- DocumentoOPTIMIZATION AND IN-VITRO CHARACTERIZATION OF ERYTHROMYCIN NANOGELS BY USING SIMPLEX-LATTICE MIXTURE DESIGNcaricato daRAPPORTS DE PHARMACIE
- DocumentoA SHORT COMMUNICATION ON THE MOLECULAR EXPRESSION ON TNBC TRIPLE NEGATIVE BREAST CANCERcaricato daRAPPORTS DE PHARMACIE
- DocumentoMOLECULAR ANALYSIS OF KEY PROTEIN PATTERN FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER (TNBC)caricato daRAPPORTS DE PHARMACIE
- DocumentoA SHORT COMMUNICATION ON PLGA AS A MAGIC POLYMER FOR THE TARGETTED DRUG DELIVERY SYSTEMcaricato daRAPPORTS DE PHARMACIE
- DocumentoEVALUATION OF HORMONAL EFFICACY OF METFORMIN THERAPY IN POLYCYSTIC OVARY SYNDROMEcaricato daRAPPORTS DE PHARMACIE
- DocumentoEFFECT OF PEGYLATED POLYPROPYLENE IMINE DENDRIMERS LOADED IMATINIB FOR ANTI-TUMOR ACTIVITYcaricato daRAPPORTS DE PHARMACIE
- DocumentoSYNTHESIS AND CHARACTERIZATION OF PEGYLATED POLYPROPYLENEIMINE (PPI) DENDRIMER LOADED PREDNISOLONE FOR ANTILEUKEMIC ACTIVITYcaricato daRAPPORTS DE PHARMACIE
- DocumentoHERBAL REVIEW ON NYCTANTHES ARBORTRISTIS LINNcaricato daRAPPORTS DE PHARMACIE
- DocumentoSYNTHESIS ANTIBACTERIAL AND ANTIFUNGAL EVALUATION OF NOVEL ARYLAZO PYRAZOLE DERIVATIVEScaricato daRAPPORTS DE PHARMACIE
- DocumentoFORMULATION AND EVALUATION OF TERBINAFINE HYDROCHLORIDE ORGANOGELS FOR TOPICAL DELIVERYcaricato daRAPPORTS DE PHARMACIE
- DocumentoDISCERNING THE ANTIOXIDANT AND MICROKINETIC POTENTIAL OF EUCALYPTUS VIMINALIS LABILL EXTRACTScaricato daRAPPORTS DE PHARMACIE
- DocumentoSIGNIFICANCE OF BOX-BEHNKEN DESIGN FOR OPTIMIZATION OF PMMA LOADED CIPROFLOXACIN NANOCARRIERS BY SILVERSON HOMOGENISERcaricato daRAPPORTS DE PHARMACIE
- DocumentoA MINI REVIEWcaricato daRAPPORTS DE PHARMACIE